BCL2L1 and Parkinson disease: There is evidence that impaired Bcl-x activity is correlated with the onset of major diseases such as Parkinson’s disease (PD) [11,12], amyotrophic lateral sclerosis [13] spinal cord muscular atrophy [14], as well as Friedrich ataxia [15], however the underlying molecular mechanisms remain poorly characterized.